Total Valuation
Lunai Bioworks has a market cap or net worth of $8.80M. The enterprise value is $16.39M.
Market Cap$8.80M
Enterprise Value$16.39M
Share Statistics
Lunai Bioworks has 4,533,890 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,533,890
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lunai Bioworks’s return on equity (ROE) is 8.34 and return on invested capital (ROIC) is 165.94%.
Return on Equity (ROE)8.34
Return on Assets (ROA)-21.63
Return on Invested Capital (ROIC)165.94%
Return on Capital Employed (ROCE)0.89
Revenue Per Employee0.00
Profits Per Employee-6.14M
Employee Count29
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lunai Bioworks is ―. Lunai Bioworks’s PEG ratio is -0.01.
PE Ratio―
PS Ratio0.00
PB Ratio-1.76
Price to Fair Value-1.76
Price to FCF-4.78
Price to Operating Cash Flow-1.15
PEG Ratio-0.01
Income Statement
In the last 12 months, Lunai Bioworks had revenue of 0.00 and earned -178.01M in profits. Earnings per share was -86.24.
Revenue0.00
Gross Profit-129.09K
Operating Income-18.55M
Pretax Income-178.01M
Net Income-178.01M
EBITDA-177.15M
Earnings Per Share (EPS)-86.24
Cash Flow
In the last 12 months, operating cash flow was -5.26M and capital expenditures -4.00, giving a free cash flow of -5.26M billion.
Operating Cash Flow-5.26M
Free Cash Flow-5.26M
Free Cash Flow per Share-1.16
Dividends & Yields
Lunai Bioworks pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change-90.51%
50-Day Moving Average2.80
200-Day Moving Average5.07
Relative Strength Index (RSI)37.96
Average Volume (3m)7.74M
Important Dates
Lunai Bioworks upcoming earnings date is May 15, 2023, TBA (Confirmed).
Last Earnings DateFeb 13, 2023
Next Earnings DateMay 15, 2023
Ex-Dividend Date―
Financial Position
Lunai Bioworks as a current ratio of 0.04, with Debt / Equity ratio of -14.77%
Current Ratio0.04
Quick Ratio0.04
Debt to Market Cap0.25
Net Debt to EBITDA-0.06
Interest Coverage Ratio-25.56
Taxes
In the past 12 months, Lunai Bioworks has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lunai Bioworks EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -6.06.
EV to Sales0.00
EV to EBITDA-0.27
EV to Free Cash Flow-6.06
EV to Operating Cash Flow-6.06
Balance Sheet
Lunai Bioworks has $3.16M in cash and marketable securities with $1.41M in debt, giving a net cash position of $1.74M billion.
Cash & Marketable Securities$3.16M
Total Debt$1.41M
Net Cash$1.74M
Net Cash Per Share$0.38
Tangible Book Value Per Share-$13.32
Margins
Gross margin is -360.71%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-360.71%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lunai Bioworks is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-63.58%